Issue link: https://viewer.e-digitaledition.com/i/778134
Currently, the CHC has nine pediatric cardiology and cardiothoracic surgery consultation locations in northern Ohio — in Cleveland, Parma, Concord Township, Medina, Mayfield Heights, Mentor, Solon, Westla ke and Youngstown. Pediatric cardiothoracic surgery is performed at UH Rainbow. "The common misconception about the collaborative is that we're sending most of our patients to Nationwide," Dr. Devaney explains. "That's really not the case. It's one program on two campuses." The CHC leverages the expertise at both institutions to optimize the care for each individual patient and improve outcomes. COMBINED RECRUITING EFFORTS The leadership tea m a lso combines forces to recruit the very best physicians. Dr. Devaney, who joined UH Rainbow and the CHC in 2016, is a prime example. Born, raised and educated through his undergraduate school years in Virginia, Dr. Devaney worked as a research chem- ist at the National Institutes of Health (NIH) Institute of Child Hea lth a nd Human Development from 1984 to 1986. Determined to be a surgeon, he obtained his MD degree from the UCLA School of Medicine followed by an internship and 10 years of residency and fellowship train- ing — first at the University of California San Francisco (UCSF) and then at the University of Michigan in Ann Arbor — in Surgery, Thoracic Surgery and Pediatric Cardiovascular Surgery. "Dr. Devaney's training at University of Michigan was under Ed Bove, one of the greatest pediatric heart surgeons of all time," says Dr. Snyder. "We (Rainbow and Nationwide) recruited Dr. Devaney from USCD's Rady Children's Hospital in San Diego where he founded and directed their cardiac transplantation program." In addition to his role as Chief of Pediatric Cardiothoracic Surgery, Dr. Devaney is involved in research, as well — mainly with two goals in mind. One is to better under- stand the molecular biology of heart failure with a focus on trying to improve cardiac function through use of novel molecular inotropes. The other is to develop technol- ogy that utilizes induced pluripotent stem (iPS) cells for diagnostic purposes and for tissue engineering. "We're trying to develop vascular patches with growth potential that can be used clinically. We're still in the bench phase for this. It's all a translational focus of research with the ultimate goal of carrying it from the bench to the bedside," he says. Another new recruit, Martin Bocks, MD, joined UH Rainbow in 2016 as Director of Pediatric Interventional Cardiology. A Michigan native, Dr. Bocks completed his medical doctorate from Wayne State University in Michigan, followed by an internship and residency in Interna l Medicine-Pediatrics and fellowships in Pediatric Cardiolog y and Pediatric Interventional Cardiac Catheterization — all at University of Michigan. Afterwards, he remained on staž there for eight years as a pediatric interventional cardiologist and an adult congenital cardiologist. "Dr. John Cheatham, a well-known inter- ventional cardiologist from Nationwide, helped us recruit Dr. Bocks. It was a true team ežort between the two hospitals," says Dr. Snyder. In fact, one of the reasons Dr. Bocks accepted the position at UH was because of the opportunity to work and collaborate with Dr. Cheatham and the other interven- tionalists at Nationwide. "I was well aware of Dr. Cheatham's accomplishments and the innovative approach he has brought to pediatric interventional cardiology — so a major reason that I took the Rainbow cath lab director position was to allow me the chance to have colleagues and men- tors here and at Nationwide through the Collaborative," he explains. "So it was a good opportunity for me to grow and take on a leadership role in a really new, interesting, innovative care model." It also ožered the opportunity to continue his research in pediatric medical device development and testing, which is currently funded by nearly $4 million in NIH grants over the next 4 years. Bioresorbable stents for cardiac applications is just one of those research projects. LEVERAGED EXPERTISE Like their CHC colleagues, Dr. Bocks and Dr. Devaney are board-certified in their respective specialty and subspe- cia lty areas. In addition, Dr. Devaney is certified by The American Board of Thoracic Surgery in Congenital Cardiac Surgery; Dr. Bocks, in Adult Congenital Heart Disease (ACHD) — a certification recently established by The American Board of Internal Medicine, in a first-time partnership with the American Board of Pediatrics. "Although many ACHD patients have heart anatomy that is better understood by pediatric cardiologists, they can also develop acquired diseases, both cardiac and non-cardiac, that require the addi- tiona l knowledge possessed by adult Monica Mielcarek, RDCS, AE, PE, Pediatric Cardiac Sonographer, UH Rainbow Babies & Children's Hospital, conducts a fetal echocardiograph as James Strainic, MD, Director, Fetal Heart Program, and Tiffanie McCourt, RN, MSN, CPNP, AC-PC, Fetal Heart Program Coordinator, look on. PHOTO COURTESY OF UNIVERSITY HOSPITALS, CLEVELAND, OH 0 7 M D N E W S . C O M /// M D N E W S C L E V E L A N D /A K R O N / C A N T O N ■ J A N U A R Y/ F E B R U A R Y 2 017